跳至主要内容
临床试验/NCT04439435
NCT04439435Unknown不适用

Evaluation of Immunoprotection Provided by Hepatitis B Vaccine After Birth in Healthy Children

Children's Hospital of Chongqing Medical University1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2020年7月最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
100
试验地点
1
主要终点
Proportion of Cellular Immunity in Children with Negative Hepatitis B Antibody

研究概览

简要总结

Worldwide, hepatitis B virus (HBV) infection is a major cause of acute hepatitis,and chronic infection with HBV often leads to chronic hepatitis, liver cirrhosis,and hepatocellular carcinoma. So far, the most effective way to prevent HBV infection in susceptible population is to inject hepatitis B vaccine. However, long-term protection against hepatitis B virus (HBV) after vaccination remains widely debated. This study aims to evaluate the existence of immune protection in healthy children with negative hepatitis B surface antibody and find a method to evaluate the immune protection induced by hepatitis B vaccine.

详细描述

One method to determine the long-term protection provided by hepatitis B vaccine against HBV infection is to estimate the cumulative incidence of chronic carrier status and breakthrough infection of previously vaccinated individuals in different periods. Up to now, no international standard suggests that hepatitis B vaccine should be used as a routine immunization program. However, it is an important issue to discuss the immune protection of healthy children with negative hepatitis B surface antibody and the duration of this protection in the future. Therefore, this study aims to evaluate the existence of immune protection of healthy children with negative hepatitis B surface antibody, find a method to evaluate the immune protection induced by hepatitis B vaccine.

The main content of the study: To recruit healthy children. Children lacking HBsAb were selected for immune memory test and receive a Hep B booster. The results of Antibody positive group and antibody negative group were compared and analyzed. To find out the most suitable method for evaluating immune protection.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
1 Year 至 15 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Children who are 1-15 years old in Chongqing
  • After birth, three injections of Hep B were inoculated in time according to the procedure of 0, 1 and 6 months(The vaccination certificate record)
  • No HBV booster vaccine given since primary HBV immunization
  • Children or guardian knew and agreed to accept the study
  • Follow - up study and blood collection after vaccination can be accepted

排除标准

  • Unwilling or impossible to participate in this research project;
  • Have a history of allergy or have had a serious vaccine reaction
  • Have immune impairment diseases and appear immune impairment;
  • Immunosuppressive treatment, receive any injection or oral administration of cortisone or cancer chemotherapy;
  • Any kind of vaccine or any kind of observation drug has been vaccinated in the past four weeks;
  • Any acute disease or other infection requiring antibiotic or antiviral treatment in the past four weeks;
  • Fever symptoms occurred in the past week ( axillary temperature ≥ 38 °C)
  • Blood transfusion experience;
  • Has a history of more serious infectious diseases ( five types of hepatitis, AIDS, syphilis, gonorrhea, etc. );
  • Hepatitis B infection or carriers(lineal relationship);
  • Abnormal physical examination

结局指标

主要结局

Proportion of Cellular Immunity in Children with Negative Hepatitis B Antibody

时间窗: 1-month

Changes of humoral and cellular immune response after hepatitis B vaccine boosters

时间窗: 1-month

次要结局

未报告次要终点

研究者

发起方
Children's Hospital of Chongqing Medical University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Qiu Li

Director

Children's Hospital of Chongqing Medical University

研究点 (1)

Loading locations...

相似试验

进行中(未招募)
不适用
Assessment of antibodies protection formation in chronic non-cirrhotic Hepatitis C carriers after being exposed to two Hepatitis B vaccine regimensChronic C hepatitis carriers (B 18.2)health controlsTo evaluate the Anti-HBs formation in chronic C hepatitis carriers (VHC) submitted to two different doses anti-HBV vaccine (Butang® vaccine) and administer the 4th additional dose in non-responders as well as assess the maintenance of seroprotectors titers in this aimed public. Besides that to evaluate the Anti-HBs formation in chronic C hepatitis carriers (VHC) immunized with Anti-HBV vaccine (Butang® vaccine) and compare them to health controls.
RBR-10ppxgw6Faculdade de Medicina da Universidade de São Paulo
已完成
不适用
Performance of the HBV ELISPOT in the Detection of the T Cellular Immune Response in Patients Infected by HBV or CuredHepatitis B
NCT02909023Hospices Civils de Lyon34
已完成
4 期
New Methods to Measure the Immune Response to Hepatitis B VaccineHepatitis B
NCT01821547University of Oxford21
招募中
不适用
Efficacy of Hepatitis B Vaccine Boosters Among Neonatally Vaccinated Children in ChongqingHepatitis B Vaccine Adverse Reaction
NCT03867643Children's Hospital of Chongqing Medical University80
已完成
不适用
Immune response to hepatitis B vaccine among HIV positive patientsCondition 1: chronic hepatitis B. Condition 2: Human Immunodeficeincy Virus.Chronic viral hepatitis B without delta-agent Chronic (viral) hepatitis BHIV disease resulting in haematological and immunological abnormalities, not elsewhere classified
IRCT2015072023251N1Vice Chancellor of Hamadan University of Medical Sciences30